tirzepatide hepatic impairment child-pugh Challenging the Dogma: Reversal of End-Stage Liver Fibrosis with in MASH Cirrhosis Wegovy is now the Pack size:1 pack Ozempic Injection

tirzepatide hepatic impairment child-pugh Challenging the Dogma: Reversal of End-Stage Liver Fibrosis with in MASH Cirrhosis Wegovy is now the Pack size:1 pack Ozempic Injection

Wegovy is now the second drug approved to treat advanced liver disease in people with fibrosis. Click the link in the comments to learn more

Serena Jingchuan Guo of the University of Florida as Jigchuan

Ozempic Injection

Pack size:1 pack

Body weight decreased similarly between the two groups throughout the 30-week study with a −3.7 and −3.6 kg reduction from baseline in the exenatide weekly and twice daily groups, respectively ( p = 0.89, Figure 2)